News

25-05-2022

Comparison of a pulsatile and a continuous flow left ventricular assist device in high-risk PCI

We are pleased to announce our newest publication in the International Journal of Cardiology from the desk of Dr. Alexander Samol, Marcus Wiemer, Sven Kaese. Mechanical circulatory support…

25-05-2022

EuroPCR 2022 Poster Presentation PULSE trial

Please follow the link below for the poster presentation by Dr. Marcelo Bastos: Effect of Pulsatile Mechanical Circulatory Support on Cardiac Mechanics (PULSE trial)…

04-04-2022

Effect of next generation pulsatile mechanical circulatory support on cardiac mechanics – The PULSE trial

We are pleased to announce our newest publication in the Cardiovascular Revascularization Medicine from the desk of Prof. Nicolas van Mieghem and Dr. Marcelo Bastos. MCS is increasingly…

01-03-2022

Transcatheter Interventions Online 2022

PulseCath is proud sponsor of the Transcatheter Interventions Online 2022. It is a free international event broadcast, led by course director, Prof. Nicolas van Mieghem from Erasmus MC,…

07-02-2022

Global Health & Pharma Magazine (GHP) awarded PulseCath

United Kingdom, 2022 – GHP has announced the winners of the Technology Awards. GHP awarded PulseCath with the Technology Awards for Best Global Circulatory Support System Manufacturer 2021. We…

25-11-2021

6th ACTOS Amsterdam CTO symposium 2-3 December 2021

PulseCath is proud sponsor of the 6th ACTOS Amsterdam CTO symposium 2-3 December 2021. Looking forward to meet you there. For more information, please follow this link….

22-11-2021

Congress CSI FOCUS D-HF in Frankfurt at December 10-11, 2021.

PulseCath is proud sponsor of the upcoming congress CSI FOCUS D-HF in Frankfurt at December 10-11, 2021. We would like to draw your attention to Friday 10th December…

16-11-2021

PulseCath named to MedTech Outlook’s Top 10 MedTech Startups in Europe 2021

PulseCath has been recognized as one of the “Top 10 MedTech Startups in Europe 2021”  by MedTech Outlook Magazine. “We take pride in honoring PulseCath as one among…

25-10-2021

PULSE-trial: Summarising the Clinical Outcomes and Benefits of iVAC 2L in Clinical Practice

In this video series, Professor Nicolas van Mieghem will discuss the benefits of iVAC 2L in clinical practice and will share the learnings and key outcomes from the…

17-09-2021

Huadong Medicine and PulseCath Announce Strategic Collaboration to Develop and Commercialize the iVAC mechanical circulatory product in Greater China

Partnership accelerates the development of the iVAC 2L mechanical circulatory device in Greater China. Expands Huadong Medicine’s medical portfolio for cases of high-risk PCI with innovative percutaneous ventricle…

Complete webinar

News

Session